Skip to Main Content

Paper Details

Identification of Small Molecule Enhancers of Immunotherapy for Melanoma.
Sci Rep
6
2020
BRAF, BRAF mutant melanoma, BRAFV600E, BRAFV600E mutant melanoma cell line, CD8+, IFN, Melanoma, Pmel-1, Pmel-1 CD8+ T-cells, SB-3123p, SB-3123p melanoma cells, T cell, co-culture cell, gp100, melanoma, melanoma cells, metastatic melanoma, patients, tumors
Author NameAffiliation
Zhiya YuCenter for Cancer Research, National Cancer Institute (NCI)
Zhiya YuCenter for Cancer Research, National Cancer Institute (NCI)
Noel SouthallDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
Noel SouthallDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
Ajit JadhavDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
Nicholas P RestifoCenter for Cancer Research, National Cancer Institute (NCI)
Nicholas P RestifoCenter for Cancer Research, National Cancer Institute (NCI)
Marc FerrerDivision of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
  • 1 - 8

Datasets

Release 1.2